Pathophysiology, Clinical Presentation, and Management of Colon Cancer

Gastroenterology Clinics of North America

Volumn 37, Issue 1, 2008, Pages 1-24

  Cappell, Mitchell S ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

CANCER PREVENTION; CANCER STAGING; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; COLONOSCOPY; COLORECTAL CANCER; ECHOGRAPHY; GASTROINTESTINAL POLYPOSIS; GENE MUTATION; HISTOLOGY; HUMAN; LABORATORY TEST; LOW DRUG DOSE; METASTASIS; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRECANCER; PROGNOSIS; REVIEW; RISK FACTOR;

COLONIC NEOPLASMS; COLONOSCOPY; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 39649124692     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2007.12.002     Document Type: Review

References (113)

1. Jamal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Hassan C., Zullo A., Laghi A., et al. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy. Dig Liver Dis 39 (2007) 242-250
3. Shibuya K., Mathers C.D., Boschi-Pinto C., et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2 (2002) 37
4. Tsai C.J., and Lu D.K. Small colorectal polyps: histopathology and clinical significance. Am J Gastroenterol 90 (1995) 988-994
5. Heald R.J., and Bussey H.J. Clinical experiences at St. Mark's Hospital with multiple synchronous cancers of the colon and rectum. Dis Colon Rectum 18 (1975) 6-10
6. Cappell M.S. From colonic polyps to colon cancer: pathophysiology, clinical presentation, and diagnosis. Clin Lab Med 25 (2005) 135-177
7. Bussey H.J.R. Familial polyposis coli: family studies, histopathology, differential diagnosis and results of treatment (1975), Johns Hopkins University Press, Baltimore (MD)
8. Stryker S.J., Wolff B.G., Culp C.E., et al. Natural history of untreated colonic polyps. Gastroenterology 93 (1987) 1009-1013
9. Winawer S.J., Zauber A.G., Fletcher R.H., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130 (2006) 1872-1885
10. Jass J.R. Hyperplastic polyps and colorectal cancer: is there a link?. Clin Gastroenterol Hepatol 2 (2004) 1-8
11. Higuchi T., and Jass J.R. My approach to serrated polyps of the colorectum. J Clin Pathol 57 (2004) 682-686
12. Chulmska A., Boudova L., and Zamecnik M. Sessile serrated adenomas of the large bowel: clinicopathologic and immunohistochemical study including comparison with common hyperplastic polyps and adenomas. Cesk Patol 42 (2006) 133-138
13. Torlakovic E., Skovlund E., Snover D.C., et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27 (2003) 65-81
14. Spring K.J., Zhao Z.Z., Karamatic R., et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131 (2006) 1400-1407
15. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
16. Huang J., Papadopoulos N., McKinley A.J., et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A 93 (1996) 9049-9054
17. Brenner DA, editors. Gastroenterology. Gastrointestinal basic science 2002-2003: the year in review. Clin Gastroenterol Hepatol 2004;2:9-13.
18. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promotor correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
19. Kambara T., Simms L.A., Whitehall V.L., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (2004) 1137-1144
20. Longacre T.A., and Fenoglio-Preiser C.M. Mixed hyperplastic adenomatous polyps/serrated adenomas: a distinct form of colorectal neoplasia. Am J Surg Pathol 14 (1990) 524-537
21. Jeevaratnam P., Cottier D.S., Browett P.J., et al. Familial giant hyperplastic polyposis predisposing to colon cancer: a new hereditary bowel cancer syndrome. J Pathol 179 (1996) 20-25
22. Goldstein N.S., Bhanot P., Odish E., et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 119 (2003) 778-796
23. Veale A.M.O. Intestinal polyposis. Eugenis Laboratory Memoirs Series 40 (1965), Cambridge University Press, New York
24. Herrera L., Kataki S., Gibas L., et al. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25 (1986) 473-476
25. Bodmer W.F., Bailey C.J., Bodmer J., et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328 (1987) 614-616
26. Kinzler K.W., Nilbert M.C., Su L.K., et al. Identification of FAP locus genes from chromosome 5q21. Science 253 (1991) 661-665
27. Robbins D.H., and Itzkowitz S.H. The molecular and genetic basis of colon cancer. Med Clin North Am 86 (2002) 1467-1495
28. Peltomaki P., Aaltonen L.A., Sistonen P., et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 260 (1993) 810-812
29. Fishel R., Lescoe M.K., Rao M.R., et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75 (1993) 1027-1038
30. Bronner C.E., Baker S.M., Morrison P.T., et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 (1994) 258-261
31. Papadopoulos N., Nicolaides N.C., Wei Y.F., et al. Mutation of a mutL homolog in hereditary colon cancer. Science 263 (1994) 1625-1629
32. Kolodner R.D., Hall N.R., Lipford J., et al. Structure of the human MSH2 locus and analysis of the two Muir-Torre kindreds for MSH2 mutations. Genomics 24 (1994) 516-526
33. Ivanovich J.L., Read T.E., Ciske D.J., et al. A practical approach to familial and hereditary colon cancer. Am J Med 107 (1999) 68-77
34. Zigman A.F., Lavine J.E., Jones M.C., et al. Localization of the Bannayan-Riley-Ruvalcaba syndrome to chromosome 10q23. Gastroenterology 113 (1997) 1433-1437
35. Nelen M.R., Padberg G.W., Peeters E.A., et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13 (1996) 114-116
36. Howe J.R., Roth S., Ringold J.C., et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280 (1998) 1086-1088
37. Jenne D.E., Reimann H., Nezu J., et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18 (1998) 38-43
38. Suraweera N., Duval A., Reperant M., et al. Evaluation of tumor microsatellite instability using five quasimonomorphic repeats and pentaplex PCR. Gastroenterology 123 (2002) 1804-1811
39. Jen J., Powell S.M., Papadopoulos N., et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54 (1994) 5523-5526
40. Miyaki M., Konishi M., Kikuchi-Yanoshita R., et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54 (1994) 3011-3020
41. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
42. Kern S.E., Fearon E.R., Tersmette K.W., et al. Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 261 (1989) 3099-3103
43. Myohanen S.K., Baylin S.B., and Herman J.G. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 58 (1998) 591-593
44. Burri N., Shaw P., Bouzourene H., et al. Methylation silencing and mutations of the p14ARF and p16NK4A genes in colon cancer. Lab Invest 81 (2001) 217-229
45. Shannon B.A., and Iacopetta B.J. Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features. Cancer Lett 167 (2001) 91-97
46. Hassan C., Zullo A., Risio M., et al. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum 48 (2005) 1588-1596
47. Kang H., O'Connell J.B., Maggard M.A., et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 48 (2005) 1161-1168
48. Green J.B., Timmcke A.E., Mitchell W.T., et al. Mucinous carcinoma: just another colon cancer?. Dis Colon Rectum 36 (1993) 49-54
49. Gryfe R. Clinical implications of our advancing knowledge of colorectal cancer genetics: inherited syndromes, prognosis, prevention, screening and therapeutics. Surg Clin North Am 86 (2006) 787-817
50. Gatalica Z., and Torlakovic E. Pathology of the hereditary colorectal carcinoma. Fam Cancer (2007) [epub June 13]
51. Janier M., Couderic L.J., Morel P., et al. Kaposi's disease in AIDS: 31 cases. Ann Dermatol Venereol 114 (1987) 185-202 [in French]
52. Cappell M.S., and Botros N. Predominantly gastrointestinal symptoms and signs in 11 consecutive AIDS patients with gastrointestinal lymphoma: a multicenter, multiyear study of 763 HIV-seropositive patients. Am J Gastroenterol 89 (1994) 545-549
53. Church J.M. Clinical significance of small colorectal polyps. Dis Colon Rectum 47 (2004) 481-485
54. Cappell M.S. The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps. Med Clin North Am 89 (2005) 1-42
55. Jessup J.M., McGinnis L.S., Steele Jr. G.D., et al. The National Cancer Data Base: report on colon cancer. Cancer 78 (1996) 918-926
56. Cress R.D., Morris C.R., and Wolfe B.M. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med 31 (2000) 447-453
57. Newcomb P.A., Norfleet R.G., Storer B.E., et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84 (1992) 1572-1575
58. Sandhu I.S., and Bhutani M.S. Gastrointestinal endoscopic ultrasonography. Med Clin North Am 86 (2002) 1289-1317
59. Fisher E.R., Sass R., Palekar A., et al. Dukes' classification revisited: findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Cancer 64 (1989) 2354-2360
60. Boland C.R., et al. Malignant tumors of the colon. In: Yamada T., Alpers D., and Kaplowitz N. (Eds). Textbook of Gastroenterology. 4th edition (2003), Lippincott Williams & Wilkins, Philadelphia 1940-1990
61. Tamura K., Ishiguro S., Munakata A., et al. Annual changes in colorectal carcinoma incidence in Japan: analysis of survey data on incidence in Aomori Prefecture. Cancer 78 (1996) 1187-1194
62. Howe H.L., Wu X., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107 (2006) 1711-1742
63. Satia-Abouta J., Galanko J.A., Martin C.F., et al. Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer 109 (2004) 728-736
64. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER cancer statistics review, 1973-1998 (2001), National Cancer Institute, Bethesda (MD) p. 1-22
65. Cappell M.S. Colon cancer during pregnancy. Gastroenterol Clin North Am 32 (2003) 341-383
66. Cappell M.S., and Goldberg E.S. The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients: a significant trend of earlier cancer detection from 1982 through 1988 at a university hospital. J Clin Gastroenterol 14 (1992) 227-235
67. Speights V.O., Johnson M.W., Stoltenberg P.H., et al. Colorectal cancer: current trends in initial clinical manifestations. South Med J 84 (1991) 575-578
68. Steinberg S.M., Barkin J.S., Kaplan R.S., et al. Prognostic indicators of colon tumors: the Gastrointestinal Tumor Study Group experience. Cancer 57 (1986) 1866-1870
69. Church T.R., Ederer F., and Mandel J.S. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 89 (1997) 1440-1448
70. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 (2004) 2704-2714
71. Smith A., Young G.P., Cole S.R., et al. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 107 (2006) 2152-2159
72. Cappell M.S., and Friedel D. The role of sigmoidoscopy and colonoscopy in the diagnosis and management of lower gastrointestinal disorders: endoscopic findings, therapy, and complications. Med Clin North Am 86 (2002) 1253-1288
73. Grem J.L., Steinberg S.M., Chen A.P., et al. The utility of monitoring carcinoembryonic antigen during systemic therapy for advanced colorectal disease. Oncol Rep 5 (1998) 559-567
74. Nystrom J.S., Weiner J.M., Heffelfinger-Juttner J., et al. Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 4 (1977) 53-58
75. Zerhouni E.A., Rutter C., Hamilton S.R., et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 200 (1996) 443-451
76. Kinkel K., Lu Y., Both M., et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224 (2002) 748-756
77. Harewood G.C., Wiersma M.J., Nelson H., et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 123 (2002) 24-32
78. Siddiqui A.A., Fayiga Y., and Huerta S. The role of endoscopic ultrasound in the evaluation of rectal cancer. Int Semin Surg Oncol 3 (2006) 36
79. Tamerisa R., Irisawa A., and Bhutani M.S. Endoscopic ultrasound in the diagnosis, staging, and management of gastrointestinal and adjacent malignancies. Med Clin North Am 89 (2005) 139-158
80. Harewood G.C. Assessment of publication bias in the reporting of EUS performance in staging rectal cancer. Am J Gastroenterol 100 (2005) 808-816
81. Ahmad N.A., Kochman M.L., and Ginsberg G.G. Endoscopic ultrasound and endoscopic mucosal resection for rectal cancers and villous adenomas. Hematol Oncol Clin North Am 16 (2002) 897-906
82. Levy M.J., Clain J.E., Gleeson F., et al. Endoscopic ultrasound guided fine needle aspiration (EUS FNA) detection of malignant iliac lymph nodes in rectal cancer. [abstract]. Gastrointest Endosc 63 5 Suppl (2006) AB97
83. Rotondano G., Esposito P., Pellecchia L., et al. Early detection of locally recurrent rectal cancer by endosonography. Br J Radiol 70 (1997) 567-571
84. Matsumoto T., Hizawa K., Esaki M., et al. Comparison of EUS and magnifying colonoscopy for assessment of small colorectal cancers. Gastrointest Endosc 56 (2002) 354-360
85. Tseng L.J., Jao Y.T., and Mo L.R. Preoperative staging of colorectal cancer with a balloon-sheathed miniprobe. Endoscopy 34 (2002) 564-568
86. Kim J.C., Kim H.C., Yu C.S., et al. Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging. Am J Surg 192 (2006) 89-97
87. Giovaninoi M., Bories E., Presenti C., et al. Three-dimensional endorectal ultrasound using a new freehand software program: results in 35 patients with rectal cancer. Endoscopy 38 (2006) 339-343
88. Tominaga T., Sakabe T., Koyama Y., et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only: five-year follow-up report. Cancer 78 (1996) 403-408
89. Greene F.L., Stewart A.K., and Norton H.J. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 236 (2002) 416-421
90. Yasuda K., Adachi Y., Shiraishi N., et al. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 8 (2001) 300-304
91. Newland R.C., Dent O.F., Lyttle M.N., et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases: a multivariate analysis of 579 patients. Cancer 73 (1994) 2076-2082
92. Compton C.C., Fielding L.P., Burgart L.J., et al. Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 979-994
93. Slentz K., Senagore A., Hibbert J., et al. Can preoperative and postoperative CEA predict survival after colon cancer resection?. Am Surg 60 (1994) 528-531
94. Wiggers T., Arends J.W., and Volovics A. Regression analysis of clinical and pathological factors in colorectal cancer after curative resections. Dis Colon Rectum 31 (1988) 33-41
95. de Haas-Kock D.F., Baeten C.G., Jager J.J., et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg 83 (1996) 781-785
96. Tsai M.S., Su Y.H., Ho M.C., et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol 14 (2007) 786-794
97. Watanabe T., Wu T.T., Catalano P.J., et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344 (2001) 1196-1206
98. Bazan V., Migliavacca M., Zanna I., et al. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients: result of a 5-year prospective study. J Cancer Res Clin Oncol 128 (2002) 650-658
99. Howe G.R., Benito E., Castelleto R., et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 84 (1992) 1887-1896
100. Hawk E.T., Umar A., Richmond E., et al. Prevention and therapy of colorectal cancer. Med Clin North Am 89 (2005) 85-110
101. Levine J.S., and Ahnen D.J. Adenomatous polyps of the colon. N Engl J Med 355 (2006) 2551-2557
102. Fuchs C.S., Giovannucci E.L., Colditz G.A., et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 340 (1999) 169-176
103. Clevers H. Colon cancer: understanding how NSAIDs work. N Engl J Med 354 (2006) 761-763
104. Thun M.J., Namboodiri M.M., and Heath Jr. C.W. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325 (1991) 1593-1596
105. Giovannucci E., Egan K., Hunter D.J., et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 333 (1995) 609-614
106. Sandler R.S., Halabi S., Baron J.A., et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348 (2003) 883-890
107. Baron J.A., Cole B.F., Sandler R.S., et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348 (2003) 891-899
108. Wadell W.R., Ganser G.F., Cerise E.J., et al. Sulindac for prophylaxis of the colon. Am J Surg 157 (1989) 175-179
109. Jacoby R.F., Cole C.E., Tutsch K., et al. Chemopreventive efficiency of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas and selective toxicity against Apc mutant embryos. Cancer Res 60 (2000) 1864-1870
110. Steinbach G., Lynch P.M., Phillips R.K., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342 (2000) 1946-1952
111. Itzkowitz S.H., Jandorf L., Brand R., et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 5 (2007) 111-117
112. Schoofs N., Deviere J., and van Gossum A. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective study. Endoscopy 38 (2006) 971-977
113. Rex D.K., and Lieberman D. ACG colorectal cancer prevention action plan: update on CT-colonography. Am J Gastroenterol 101 (2006) 1410-1413